1. 210 Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients. (September 2015) Authors: Griseri, P.; Garrone, O.; Lo Sardo, A.; Monteverde, M.; Rusmini, M.; Tonissi, F.; Merlano, M.; Bruzzi, P.; Ceccherini, I.; Nigro, C. Lo Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3346 BeyPro1: a Phase II single-arm study for the treatment after recurrence of advanced melanoma patients harboring the V600BRAF mutation and pretreated with Vemurafenib, with the association of Vemurafenib plus Fotemustine. (September 2015) Authors: Queirolo, P.; Spagnolo, F.; Picasso, V.; Simeone, E.; Grimaldi, A.M.; Curvietto, M.; Giorello, L.; Fontana, V.; Merlo, D.F.; Ascierto, P.A.; Bruzzi, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis. (June 2017) Authors: Poggio, F.; Ceppi, M.; Lambertini, M.; Bruzzi, P.; Ugolini, D.; Bighin, C.; Levaggi, A.; Giraudi, S.; D'Alonzo, A.; Vaglica, M.; Blondeaux, E.; Sertoli, M.R.; Pronzato, P.; Del Mastro, L. Journal: Breast Issue: Volume 33(2017) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study. (October 2019) Authors: Merlano, M.; Denaro, N.; Benasso, M.; Licitra, L.; Bossi, P.; Locati, L.; Vecchio, S.; Bruzzi, P. Journal: Oral oncology Issue: Volume 97(2019) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Initial serum (1, 3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil. (October 2015) Authors: Giacobbe, D.R.; Esteves, P.; Bruzzi, P.; Mikulska, M.; Furfaro, E.; Mesini, A.; Tatarelli, P.; Grignolo, S.; Viscoli, C.; Colombo, A.L.; Del Bono, V. Journal: Clinical microbiology and infection Issue: Volume 21:Number 10(2015:Oct.) Page Start: 954.e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Innovation in oncology clinical trial design. (March 2019) Authors: Hanauske, ; Wacheck, V.; Collignon, O.; Bruzzi, P.; Gross, J.; Riehl, T.; Bretz, F.; Dollins, ; Radtke, I.; Verweij, J.; Hendriks, H.R.; Zwierzina, H. Journal: Cancer treatment reviews Issue: Volume 74(2019) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short term increase in risk of breast cancer after full term pregnancy. Issue 6656 (29th October 1988) Authors: Bruzzi, P.; Negri, E.; La Vecchia, C.; Decarli, A.; Palli, D.; Parazzini, F.; Del Turco, M. R. Journal: BMJ Issue: Volume 297:Issue 6656(1988) Page Start: 1096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The sacral chordoma margin. Issue 8 (August 2020) Authors: Radaelli, S.; Fossati, P.; Stacchiotti, S.; Akiyama, T.; Asencio, J.M.; Bandiera, S.; Boglione, A.; Boland, P.; Bolle, S.; Bruland, Ø.; Brunello, A.; Bruzzi, P.; Campanacci, D.; Cananzi, F.; Capanna, R.; Casadei, R.; Cordoba, A.; Court, C.; Dei Tos, A.P.; DeLaney, T.F. Journal: European journal of surgical oncology Issue: Volume 46:Issue 8(2020) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗